Aptamer hails two "key" contract wins; eyes revenue to beat prior year
(Alliance News) - Aptamer Group PLC on Friday announced new contracts as it expects annual revenue to further grow. Read More
| Price | 0.775p on 10-12-2025 at 19:10:05 |
|---|---|
| Change | -0.05p -6.25% |
| Buy | 0.80p |
| Sell | 0.75p |
| Last Trade: | Sell 500.00 at 0.75p |
| Day's Volume: | 7,863,740 |
| Last Close: | 0.75p |
| Open: | 0.80p |
| ISIN: | GB00BNRRP542 |
| Day's Range | 0.75p - 0.75p |
| 52wk Range: | 0.23p - 1.30p |
| Market Capitalisation: | £20.23m |
| VWAP: | 0.790908p |
| Shares in Issue: | 2.70b |
Sector: Medicine and Biotech
Listed In: FTSE AIM All-Share,
Aptamer Group (APTA) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Sell* | 500 | 0.75p | Uncrossing Trade |
16:35:26 - 10-Dec-25 |
| Buy* | 40,146 | 0.78p | Ordinary |
16:17:18 - 10-Dec-25 |
| Buy* | 625,078 | 0.7999p | Ordinary |
15:50:24 - 10-Dec-25 |
| Unknown* | 1,000,000 | 0.78p | Ordinary |
15:50:06 - 10-Dec-25 |
| Unknown* | 2,500,000 | 0.80p | Negotiated Trade |
15:46:35 - 10-Dec-25 |
| Buy* | 179,868 | 0.7995p | Ordinary |
15:45:48 - 10-Dec-25 |
| Buy* | 523,506 | 0.80p | Ordinary |
14:52:27 - 10-Dec-25 |
| Buy* | 5,000 | 0.7995p | Ordinary |
13:40:12 - 10-Dec-25 |
| Unknown* | 34,822 | 0.775p | Ordinary |
13:39:50 - 10-Dec-25 |
| Buy* | 62,040 | 0.7995p | Ordinary |
13:14:21 - 10-Dec-25 |
Aptamer Group (APTA) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 27th Nov 2025 1:01 pm | RNS | Results of 2025 Annual General Meeting |
| 27th Nov 2025 7:00 am | RNS | AGM Statement |
| 14th Nov 2025 7:00 am | RNS | Strong contract wins build commercial momentum |
| 4th Nov 2025 7:00 am | RNS | New contract with top five pharma company |
| 3rd Nov 2025 7:00 am | RNS | Posting of Annual Report and Notice of AGM |
| 14th Oct 2025 7:00 am | RNS | Full Year Results for the 12mths to 30 June 2025 |
| 13th Oct 2025 7:00 am | RNS | New contract with top 10 pharma |
| 10th Oct 2025 7:00 am | RNS | Notice of Results, Analyst & Investor Presentation |
| 8th Oct 2025 7:00 am | RNS | Major top 3 global pharma contract win |
| 26th Sep 2025 7:00 am | RNS-R | Investor Event and Presentation |